Search Results

Companies join hands to address HPV burden in resource-poor areas

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 588, 2009-10-03 , pp. 10-10(1)

Publisher: Adis International

Market growth for acute-HF drugs expected

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 572, 2009-02-21 , pp. 10-10(1)

Publisher: Adis International

Cancer patients in Alberta, Canada, will now have better access to aprepitant

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 564, 2008-10-18 , pp. 9-9(1)

Publisher: Adis International

Canadian First Nations people living with HIV/AIDS will now have access to raltegravir

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 564, 2008-10-18 , pp. 9-9(1)

Publisher: Adis International

Merck & Co's live, oral, pentavalent rotavirus vaccine [Rotateq] has been awarded prequalification status by WHO.

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 564, 2008-10-18 , pp. 10-10(1)

Publisher: Adis International

The province of Quebec has announced that it will include sitagliptin [Januvia], under some reimbursement criteria

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 564, 2008-10-18 , pp. 11-11(1)

Publisher: Adis International

Merck has announced plans to evaluate a once-daily investigational dose of raltegravir in the QDMRK trial.

Source: Inpharma, Volume 1, Number 1660, 2008-10-18 , pp. 8-8(1)

Publisher: Adis International

More seeds of doubt sewn about integrity of big pharma

Source: Inpharma, Volume 1, Number 1657, 2008-09-27 , pp. 2-2(1)

Publisher: Adis International

Novel hepatitis B vaccine more than a match for standard

Source: Inpharma, Volume 1, Number 1651, 2008-08-16 , pp. 11-11(1)

Publisher: Adis International

ENHANCE fallout − coverage and prescribing in leading health plans

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 552, 2008-05-03 , pp. 6-6(1)

Publisher: Adis International

The US FDA has placed a clinical hold on HEPLISAV, an investigational hepatitis B vaccine

Source: Reactions, Volume 1, Number 1196, 2008-04-05 , pp. 4-4(1)

Publisher: Adis International

The US FDA has placed a clinical hold on HEPLISAV, an investigational hepatitis B vaccine

Source: Inpharma, Volume 1, Number 1632, 2008-04-05 , pp. 25-25(1)

Publisher: Adis International

Merck has been criticised by the AHF over the announced price for its key new HIV/AIDS drug, raltegravir [Isentress].

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 539, 2007-10-20 , pp. 11-11(1)

Publisher: Adis International

Merck has offered to reduce the price of efavirenz in Thailand, but with the condition that the country revokes its compulsory license for the drug.

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 530, 2007-06-16 , pp. 11-11(1)

Publisher: Adis International

NVIC warns of HPV vaccine recombinant quadrivalent concerns

Source: Reactions, Volume 1, Number 1141, 2007-03-03 , pp. 3-3(1)

Publisher: Adis International

Dr Reddy's Laboratories has announced the launch of its finasteride and simvastatin tablets

Source: Inpharma, Volume 1, Number 1544, 2006-07-01 , pp. 22-22(1)

Publisher: Adis International

Novartis' dipeptidyl peptidase IV inhibitors sitagliptin and vildagliptin are set to achieve blockbuster status in the type 2 diabetes mellitus (DM) market

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 487, 2005-09-24 , pp. 14-14(1)

Publisher: Adis International

Vioxx may return to Canadian market if requested?

Source: Reactions, Volume 1, Number 1060, 2005-07-16 , pp. 2-2(1)

Publisher: Adis International

Vioxx may return to Canadian market if requested?

Source: Inpharma, Volume 1, Number 1496, 2005-07-16 , pp. 17-17(1)

Publisher: Adis International

Gaboxadol significantly improves key sleep measures in patients with primary insomnia

Source: Inpharma, Volume 1, Number 1494, 2005-07-02 , pp. 9-9(1)

Publisher: Adis International